Clinical Study to Evaluate the Effects of Cevostamab in Patients with Lupus with or without Active Lupus Nephritis

2025-522904-26-00 Protocol GA46280 Human pharmacology (Phase I) - Other Authorised, recruitment pending

Status Authorised, recruitment pending · 4 EU/EEA countries · 11 sites · Protocol GA46280

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - Other
Status Authorised, recruitment pending
Participants planned 46
Countries 4
Sites 11

Systemic Lupus Erythematosus (SLE) With or Without Active Lupus Nephritis (LN)

Key facts

Sponsor
Genentech Inc.
Participant type
Patients
Age range
18-64 years, 65+ years
Gender
Male and Female
Therapeutic area
Diseases [C] - Immune System Diseases [C20]
Decision date (initial)
2026-04-22
Transition trial
No
Low-intervention
No
Rare-disease indication
No
Vulnerable population
Yes

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Systemic Lupus Erythematosus (SLE) With or Without Active Lupus Nephritis (LN)

VersionLevelCodeTermSystem organ class
21.1 PT 10042945 Systemic lupus erythematosus 100000004859

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Genentech Inc.

Sponsor organisation
Genentech Inc.
Address
1 Dna Way
City
South San Francisco
Postcode
94080-4918
Country
United States

Scientific contact point

Organisation
Genentech Inc.
Contact name
US Program Manager Product Development Regulatory

Public contact point

Organisation
Genentech Inc.
Contact name
US Program Manager Product Development Regulatory

Locations

4 EU/EEA countries · 11 investigational sites

By country

CountryMS statusPlanned subjectsSites
France Authorised, recruitment pending 4 3
Germany Authorised, recruitment pending 3 2
Italy Authorised, recruitment pending 6 3
Spain Authorised, recruitment pending 4 3
Rest of world
Argentina, Brazil, Australia, China
29

Investigational sites

France

3 sites · Authorised, recruitment pending
Centre Hospitalier Universitaire De Toulouse
Néphrologie et transplantation d'organes, 1 Avenue Du Professeur Jean Poulhes, Tsa 50032, Toulouse Cedex 9
Hospices Civils De Lyon
Médecine interne, 5 Place D Arsonval, 69437, Lyon Cedex 03
Centre Hospitalier Universitaire De Poitiers
Néphrologie, hémodialyse et transplantation rénale, 2 Rue De La Miletrie, 86000, Poitiers

Germany

2 sites · Authorised, recruitment pending
LMU Klinikum Muenchen AöR
NA, Pettenkoferstrasse 8a, Ludwigsvorstadt-Isarvorstadt, Munich
Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR
NA, Langenbeckstrasse 1, Oberstadt, Mainz

Italy

3 sites · Authorised, recruitment pending
Humanitas Mirasole S.p.A.
Rheumatology and Clinical immunology, Via Alessandro Manzoni 56, 20089, Rozzano
Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia
UO Nephrology, Piazzale Spedali Civili 1, 25123, Brescia
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
UOC Rheumatology, Largo Francesco Vito 1, 00168, Rome

Spain

3 sites · Authorised, recruitment pending
Clinica Universidad De Navarra
Nephrology, Pio XII Etorbidea 36, 31008, Pamplona
Hospital Universitario Virgen De La Macarena
Nephorology, Avenida Del Doctor Fedriani 3, 41009, Sevilla
Hospital Universitario Araba
Rheumatology, Jose Achotegui Kalea S/N, 01009, Vitoria

Application history

1 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2025-12-17 Spain Acceptable
2026-04-20
2026-04-22